Poland's largest pharma scouts for joint bidder in potential $4B buyout of former Sanofi generics unit: Reuters
The generics sector may see even more consolidation. Zentiva, once Sanofi’s European generics unit, is said to have attracted buyout interest.
Source: fiercepharma.com